Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30(+) Malignancies
将双特异性 CD30/CD16 抗体 AFM13 与细胞因子激活的血液和脐带血来源的 NK 细胞联合使用,可促进针对 CD30(+) 恶性肿瘤的 CAR 样反应。
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-0164
Kerbauy, Lucila N; Marin, Nancy D; Kaplan, Mecit; Banerjee, Pinaki P; Berrien-Elliott, Melissa M; Becker-Hapak, Michelle; Basar, Rafet; Foster, Mark; Garcia Melo, Luciana; Neal, Carly C; McClain, Ethan; Daher, May; Nunez Cortes, Ana Karen; Desai, Sweta; Inng Lim, Francesca Wei; Mendt, Mayela Carolina; Schappe, Timothy; Li, Li; Shaim, Hila; Shanley, Mayra; Ensley, Emily L; Uprety, Nadima; Wong, Pamela; Liu, Enli; Ang, Sonny O; Cai, Rong; Nandivada, Vandana; Mohanty, Vakul; Miao, Qi; Shen, Yifei; Baran, Natalia; Fowlkes, Natalie W; Chen, Ken; Muniz-Feliciano, Luis; Champlin, Richard E; Nieto, Yago L; Koch, Joachim; Treder, Martin; Fischer, Wolfgang; Okamoto, Oswaldo Keith; Shpall, Elizabeth J; Fehniger, Todd A; Rezvani, Katayoun
肿瘤
肿瘤免疫
细胞生物学
CD30
CD3
CD16
NK 细胞
免疫/内分泌